Pfizer Inc.won expanded federal approval Thursday to market the first pharmaceutical treatment for fibromyalgia, a mysterious condition marked by severe muscle pain and debilitating fatigue.
The medication, Lyrica, known generically as pregabalin, had previously gained FDA approval to treat, among other conditions as partial seizures and neuralgia
